Novo Nordisk tested once-daily oral semaglutide tablet in 667 people with obesity or overweight with at least one comorbidity.
Thats slightly more than those taking injectable Wegovy.
In the latest study, the company tested a 50-mg dose for weight loss.
Photo Illustration by Zack Angeline for Verywell Health; Getty Images.
Side Effects
So far, side effects of a tablet appear similar to side effects of injections.
Novo Nordisk said patients most commonly experienced these adverse events when their dosage was increased.
The company hasnt yet shared the full results of its clinical trial data.
But oral semaglutide comes with its own limitations.
I think more flexibility is always a good thing for people.
In rare instances, patients may experience allergic reactions at the site of the injection.
Manalac said that drugmakers have come a long way in creating self-injection pens that can be used fairly comfortably.
Still, there are likely to be many patients who are turned off by the idea of injections.
Talk with a healthcare provider about your lifestyle and which weight loss regimen is right for you.
